 |
|
|
 |
Jose Ignacio Labarta Aizpún |
 |
 |
 |
|
Profesor Asociado en Ciencias de la Salud
|
| |
|
Unidad de
Endocrinología
Servicio de Pediatría
Hospital Universitario
Miguel Servet
Zaragoza 50009
|
Teléfono: 976 765500 (ext. 3475)
E-mail: jilabarta@terra.es |
|
Principales líneas de investigación
- Endocrinopatías infantiles: diagnóstico precoz, tratamiento y evolución a largo plazo
- Crecimiento y desarrollo humano, normal y patológico
- Hormona de crecimiento y factores de crecimiento similares a la insulina
Trabajos publicados
- Labarta JI, Ruiz JA, Molina I, De Arriba A, Mayayo E, FerrándezLongás A. Growth and growth hormone treatment in short stature children born small for gestational age. L. Pediatr Endocrinol Rev 2009; 6 Suppl 3: 3507.
- Labarta JI, Bello E, RuizEcharri M, Rueda C, Martul P, Mayayo E, Ferrández Longás A. Childhoodonset congenital adrenal hyperplasia: longterm outcome and optimization of therapy. J Pediatr Endocrinol Metab 2004; 17 Suppl 3: 41122.
- Ferrández Longas A, Baguer L, Labarta JI, Labena C, Mayayo E, Puga B, Rueda C, RuizEcharri M. Longitudinal study of normal spanish children from birth to adulthood anthropometric, puberty, radiological and intelellectual data. Pediatr Endocrinol Rev 2005; 2 Suppl 4: 425.
- Travers SH, Labarta JI, Gargosky SE, Rosenfeld RG, Jeffers BW, Eckel RH. Insulinlike growth factor binding proteinI levels are strongly associated with insulin sensitivity and obesity in early pubertal children. J Clin Endocrinol Metab 1998; 83(6): 19359.
- Labarta JI, Gargosky SE, Simpson DM, Lee PD, Argente J, GuevaraAguirre J, Rosenfeld RG. Immunoblot studies of the acid labile subunit (ALS) in biological fluids, normal human serum and in children with GH deficiency and GH receptor deficiency before and after longterm therapy with GH or IGFI respectively. Clin Endocrinol (Oxf) 1997; 47(6): 65766.
|
|
|
|
